A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)

Patrick P. J. Phillips, Kelly E. Dooley, Stephen Henry Gillespie, Norbert Heinrich, Jason E. Stout, Payam Nahid, Andreas H. Diacon, Rob E. Aarnoutse, Gibson S. Kibiki, Martin J. Boeree, Michael Hoelscher

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)
2 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science